Meedoen met studie Home Meedoen met studie 4

In vivo dosimetry in MUPIT applications-a feasibilitiy study

Titel In vivo dosimetry in MUPIT applications-a feasibilitiy study
Auteurs F.J.W.M. Dankers (Radboudumc-Nijmegen), A. Loopstra, L.H.M. Mestrom, M.A.D. Haverkort, E.M. van der Steen-Banasik, M.P.R. van Gellekom
Aandachtsgebied Brachytherapie, Gynaecologie
Samenvatting To investigate the feasibility of in vivo dosimetry using microMOSFET dosimeters in patients treated with brachytherapy using the MUPIT applicator.
Datum 1 januari 2016
Locatie Arnhem
Link naar PubMed

Automated transfer of absolute couch coordinates to the R&V system

Titel Automated tranfer of absolute couch coordinates to the R&V system to prevent gross set-up incidents
Auteurs xx
Aandachtsgebied Innovatie
Samenvatting We developed and implemented an automated transfer of absolute couch coordinates and the site-specific tolerance table to the R&V system. This improves patient safety by preventing gross set-up incidents and decreases the workload.
Datum 7 mei 2016
Locatie Arnhem
Link naar PubMed

6 Years’ experience with HDR Brachytherapy in bladder implantations

Titel 6 Years’ Experience With HDR Brachytherapy In Bladder Implantations Performed Laparoscopically In Solitary Bladder Tumors. A Prospective Study
Auteurs Elzbieta van der Steen-Banasik, Geert Smits, Bernard Oosterveld, Theo Janssen, Dorien Haverkort, Carl Wijburg, Andries Visser
Aandachtsgebied Brachytherapie, Urologie
Doel In our institution laparoscopic bladder implantations were performed since June 2009. In December 2009 a HDR schedule was introduced, replacing the former PDR schedule. In addition laparoscopy was modernized with the introduction of a robot. Here we report our 6 year experience.
Startdatum 4 februari 2016
Locatie Arnhem
Link naar PubMed

Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints

Titel Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
Auteurs Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M.
Aandachtsgebied Brachytherapy, Urologie
Samenvatting Salvage Iodine-125 brachytherapy (I-125-BT) constitutes a curative treatment approach for patients with organ-confined recurrent prostate cancer after primary radiotherapy. Currently, focal salvage (FS) instead of whole-gland or total salvage (TS) is being investigated, to reduce severe toxicity associated with cumulative radiation dose. Differences in urethral and bladder dosimetry and constraints to reduce late (> 90 days) genitourinary (GU) toxicity are presented here.
Datum september 2015
Locatie Radiother Oncol. 2015 Nov;117(2):262-9. doi: 10.1016/j.radonc.2015.08.018. Epub 2015 Sep 5.
  Link naar PubMed

START TYPING AND PRESS ENTER TO SEARCH